Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 17, 2026
TickeronGET DAILY SIGNALS
Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?

Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?

Key Takeaways

  • Shares of AIRS fell 11.37% to $3.04 in Monday trading, down $0.39 from Friday’s close of $3.43.
  • The decline extends post-earnings turbulence following the company’s August 10 second-quarter report.
  • Q2 revenue of $42.9 million missed consensus and fell 3% year over year; the full-year adjusted EBITDA outlook was cut to $12–$14 million.
  • No fresh company-specific announcement was apparent during Monday’s slide, pointing to technical and sentiment-driven selling.
  • Traders are watching the $3.00 area and upcoming Q3 case-volume and margin trends.

Opening Summary

AirSculpt Technologies, Inc. (AIRS) is a provider of minimally invasive body contouring procedures in the United States and Canada. In Monday afternoon trading, shares dropped 11.37% to $3.04, compared with Friday’s close of $3.43. The decline extended a period of elevated volatility that began when the company reported second-quarter results on August 10, and the market’s immediate focus remained on the weaker profitability outlook rather than on any new corporate announcement.

Q2 Results and Lowered Profit Outlook

The primary overhang on AIRS remains the second-quarter report released before the market open on August 10. Revenue came in at $42.9 million, down 3% from $44.0 million a year earlier and below the consensus estimate of roughly $44.2 million. Net loss widened to $1.1 million from $0.6 million in the prior-year period, while adjusted EBITDA declined to $4.9 million from $5.8 million.

Management reaffirmed full-year revenue guidance but said results are expected to track toward the lower end of the $151 million-to-$157 million range. More importantly for investor sentiment, the company reduced its full-year adjusted EBITDA guidance to $12 million-to-$14 million. That downward revision to profitability expectations has kept selling pressure on the stock even after the initial post-earnings reaction.

Technical Selling and Post-Earnings Volatility

The stock’s recent path illustrates how volatile AIRS has become. The shares closed at $5.01 on August 7, then collapsed to $2.75 on August 10 after the earnings release. A partial recovery followed over the next four sessions, lifting the stock back to $3.43 by August 14. Monday’s slide to $3.04 unwound most of that rebound in a single session.

With a beta near 2.4 and a relatively small float, AIRS is prone to outsized intraday moves. The absence of a fresh company-specific catalyst during Monday’s decline suggests that the move was driven by continued digestion of the lowered earnings outlook, profit-taking after last week’s bounce, and momentum-driven selling once the shares surrendered key short-term support.

Market Context and Trading Activity

Turnover in AIRS has been elevated relative to early-August levels since the earnings report. Daily volume surged to roughly 2.5 million shares on August 10 and remained well above the early-August baseline in subsequent sessions, reflecting intense two-way trading as investors repositioned.

The selling on Monday appeared largely company-specific rather than tied to a broad market catalyst. The stock’s slide below the $3.30 level and toward $3.00 placed it back near the lower end of its recent post-earnings range, a technical breakdown that likely contributed to additional selling pressure during the afternoon.

What Comes Next for AIRS

Investors will be watching whether AIRS can stabilize above the $3.00 level or whether the post-earnings range continues to compress. The next scheduled quarterly report is expected in November, and management commentary on same-center case volumes, revenue per case, and adjusted EBITDA margins will be central to the investment debate.

Additional focus areas include the rollout of newer procedures such as skin tightening and skin removal, the planned AlloClae pilot, demand trends among GLP-1 patients, and progress on debt refinancing. Consumer spending on elective cosmetic procedures remains a key macroeconomic risk, and the company’s ability to convert higher marketing investment into sustained case growth will likely determine whether the recent volatility gives way to a more durable trend.

Trending AI Robots

Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are featured in its curated Trending AI Robots section. These bots vary by strategy, timeframe, performance metrics, and traded symbols, allowing traders to explore automated approaches tailored to different market environments. Investors seeking a data-driven way to monitor opportunities across active tickers may find the section a useful starting point.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AIRS

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AIRS's Stochastic Oscillator is staying in oversold zone for 1 day

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where AIRS's RSI Indicator exited the oversold zone, 30 of 36 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.

Following a +44.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where AIRS advanced for three days, in 235 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

AIRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 06, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AIRS as a result. In 66 of 72 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for AIRS turned negative on November 06, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 38 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AIRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for AIRS entered a downward trend on November 10, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 1 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.367) is normal, around the industry mean (204.532). P/E Ratio (-2.966) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). AIRS's Dividend Yield (3.072) is considerably higher than the industry average of (0.154). P/S Ratio (0.921) is also within normal values, averaging (2.688).

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. AIRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AIRS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.37B. The market cap for tickers in the group ranges from 20.9K to 107.17B. HCA holds the highest valuation in this group at 107.17B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -6%. For the same Industry, the average monthly price growth was 0%, and the average quarterly price growth was 11%. ARDT experienced the highest price growth at 53%, while NIVF experienced the biggest fall at -67%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 57%. For the same stocks of the Industry, the average monthly volume growth was 48% and the average quarterly volume growth was 13%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 46
Price Growth Rating: 51
SMR Rating: 66
Profit Risk Rating: 82
Seasonality Score: -1 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Industry
N/A
Address
1111 Lincoln Road
Phone
+1 786 709-9690
Employees
453
Web
https://www.airsculpt.com
Interact to see
Advertisement
AtlasClear Holdings (ATCH) shares fell roughly 25.5% over the last 30 days, declining from $0.1881 on October 2 to $0.1401 on October 30. The pullback extended a longer downtrend that has kept the stock trading well below the $1.00 NYSE American minimum, keeping continued listing-compliance risk in focus.
The central target of $1,620 is the arithmetic mean of verified, current analyst price targets, rounded to a clean level; it is not a single firm's forecast or a guarantee. At a recent price of about $690 , reaching $1,620 would require a gain of roughly 135% , a very large move by any standard.
NVDA fell -2.10% to $216.66 during regular trading, down from a prior close of $221.30. Primary catalyst: hotter-than-expected September CPI data reignited Fed rate-hike fears, raising borrowing costs for AI infrastructure buildouts.
XRPN fell -9.70% in early regular-session trading on Tuesday, sliding from Monday's $10.41 close to $9.40. The decline follows a November 9 SEC prospectus disclosing a committed equity facility with Cantor to sell up to 5.2 million new Class A shares at 97% of the volume-weighted average price, implying up to roughly 16.7% potential dilution.
The $1.14 central target is not an analyst consensus; it is the all-cash merger consideration in GoPro, Inc. (GPRO) 's pending deal with Starman Optical, agreed in September 2026. With the stock trading near $0.88, reaching $1.14 would require a move of roughly 29.5%.
Why Is AirSculpt Technologies (AIRS) Stock Down -11.37% Today?